CytomX Therapeutics is a Biotech company based in San Francisco. It has raised $136M in total funding. Latest round: IPO.
CytomX Therapeutics funding overview
CytomX Therapeutics is a Biotech company based in San Francisco. CytomX Therapeutics has raised $136M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is an IPO. Investors on record include Fidelity Investments, Canaan Partners, Third Rock Ventures. 3 distinct backers are named across the disclosed rounds.
CytomX Therapeutics at a glance
Total raised
$136M
Latest round
IPO
Industry
Biotech
Headquarters
San Francisco
Notable investors
Fidelity Investments, Canaan Partners, Third Rock Ventures
Frequently asked about CytomX Therapeutics funding
How much has CytomX Therapeutics raised?
CytomX Therapeutics has raised $136M in total disclosed funding across the rounds on record.
Who has invested in CytomX Therapeutics?
Fidelity Investments, Canaan Partners, Third Rock Ventures are named among the investors backing CytomX Therapeutics.
What was the latest CytomX Therapeutics funding round?
The most recent disclosed round is an IPO.
Where is CytomX Therapeutics based?
CytomX Therapeutics is based in San Francisco.
What sector does CytomX Therapeutics operate in?
CytomX Therapeutics is tracked under Biotech from San Francisco, with $136M in disclosed funding.
Round data for CytomX Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in San Francisco and backer lists below.
